🔎 Trials Near Me

Home › Kanser sa Bato (Renal Cell Carcinoma) › California › San Diego

Pag-aaral pangklinika para sa Kanser sa Bato (Renal Cell Carcinoma) sa San Diego, CA

14 pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng San Diego (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

Nagre-recruitPhase 1
  • Research Site, San Diego
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05536141

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Nagre-recruitPhase 1
  • NEO-811 San Diego Site, San Diego
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07300241

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Nagre-recruitPhase 1
  • University of California San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06234605

DESTINY-PANTUMOUR04

Nagre-recruitObservasyonal na pag-aaral
  • Research Site, San Diego
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Nagre-recruitObservasyonal na pag-aaral
  • University of California San Diego, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04981119

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Nagre-recruitPhase 2
  • University of California San Diego, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Nagre-recruitPhase 2
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05327686

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Nagre-recruitPhase 1/2
  • UC San Diego Medical Center - Bankers Hill, San Diego
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • at 5 pa
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Nagre-recruitPhase 1
  • University of California San Diego Medical Center, Moores Cancer Center, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07195916

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Nagre-recruitObservasyonal na pag-aaral
  • University of California, San Diego, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT05059444

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Nagre-recruitPhase 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT06661720

Retifanlimab and Ruxolitinib In Solid Malignancies

Nagre-recruitPhase 1/2
  • University of California, San Diego Moores Cancer Center, La Jolla · 11 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Ene 13, 2026 · NCT07219576

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Nagre-recruitPhase 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT06682793

A Beta-only IL-2 ImmunoTherapY Study

Nagre-recruitPhase 1/2
  • Sharp Memorial Hospital, San Diego
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

Pag-aaral para sa Kanser sa Bato (Renal Cell Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa San Diego

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.